The amendments made based on recommendations of the Association of the Russian Pharmaceutical Manufacturers on the issuance of the CT-1 certificates were adopted and signed by CCI President, Sergey Katyrin.

The ARPM have been appealing to make amendments to the existing orders in order to simplify the issuance procedure of the CT-1 certificate. The recently made amendments fully appeal to concerns by the Association company-members. These amendments were made to orders #93 and #94. They include the extension of the certificate to one year, the possibility of issuing a certificate for packaged medicines in Russia until December 31, 2016, the exclusion of notarial documents necessary for the application, and the elimination of requirements for experts to visit the production sites.

“We collected and analyzed all problems and systemic issues during the issuance of the CT-1 certificate by regional CCI chambers. We appealed to the CCI to make amendments to their policy. The agency’s industry divisions supported the majority of our proposals and as the result those officially made. We thank our colleagues for a productive work,” said ARPM Director General, Victor Dmitriev.

The made corrections will help to simplify the procedure for obtaining certificates for businesses and will lead to a single mechanism used by regional Chambers of Commerce.